The relaxation effect of endocannabinoid anandamide on isolated rat bladder and vas deferens tissues and possible mechanisms
Fundamental & Clinical Pharmacology · 2024-10 · 38 (5) · 967-977
DOI: 10.1111/fcp.13008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fundamental & Clinical Pharmacology, online erschienen am 07.05.2024. Verfasst von Yagmur Okcay und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Gulhane Faculty of Pharmacy, University of Health Sciences Türkiye, Etlik/Kecioren/Ankara, Turkey. Hauptthemen laut MEDLINE: Endocannabinoids, Polyunsaturated Alkamides, Vas Deferens, Rats, Wistar. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Sağlık Bilimleri Üniversitesi.
Abstract (Originalsprache)
Background
The endocannabinoid system plays important roles in various systems, including the genitourinary system; however, its mechanism of action is not fully understood.
Objectives
This study aimed to investigate the direct relaxant effects of anandamide and its possible mechanisms in isolated rat bladder and vas deferens tissues.
Methods
Twenty‐one adult male Wistar albino rats were used. Bladder and vas deferens (prostatic and epididymal portions) tissues were mounted in 10 mL of organ baths. Relaxation responses to anandamide were recorded at 3 and 10 μM concentrations. After the rest period, the procedures were repeated in the presence of cannabinoid (CB) and vanilloid receptor antagonists, various potassium channel blockers, cyclo‐oxygenase, and nitric oxide synthase inhibitors. In different tissues to investigate the Ca 2+ ‐channel antagonistic effect of anandamide, concentration–response curves to CaCl 2 were obtained in the absence and presence of anandamide.
Results
Anandamide caused a significant relaxation response in the bladder and epididymal vas deferens tissues, but not in the prostatic portion. The effect of anandamide was antagonized in the presence of the CB 1 antagonist AM251 or the non‐selective potassium channel blocker tetraethylammonium in bladder tissue. In the epididymal vas deferens, anandamide significantly inhibited the calcium contraction responses, especially at high concentrations. The CB 2 antagonist AM630 reversed this inhibition.
Conclusions
The results show that anandamide has a direct relaxant effect on the isolated rat bladder and epididymal vas deferens. Anandamide triggers different mechanisms in different types of tissues, and further studies are needed to elucidate the mechanism of action of anandamide.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Gulhane Faculty of Pharmacy, University of Health Sciences Türkiye, Etlik/Kecioren/Ankara, Turkey.
- Department of Medical Pharmacology, Gulhane Faculty of Medicine, University of Health Sciences Türkiye, Etlik/Kecioren/Ankara, Turkey.
ORCID-Profile: Ismail Mert Vural
Förderung
- Sağlık Bilimleri Üniversitesi
Zitieren
APA
Okcay, Y., Onal Sis, C., Ozpolat, M. C., Rumanli, Z., Ulusoy, K. G., Yildiz, O., & Vural, I. M. (2024). The relaxation effect of endocannabinoid anandamide on isolated rat bladder and vas deferens tissues and possible mechanisms. Fundamental & Clinical Pharmacology, 38(5), 967-977. https://doi.org/10.1111/fcp.13008
Vancouver
Okcay Y, Onal Sis C, Ozpolat MC, Rumanli Z, Ulusoy KG, Yildiz O, et al. The relaxation effect of endocannabinoid anandamide on isolated rat bladder and vas deferens tissues and possible mechanisms. Fundamental & Clinical Pharmacology. 2024;38(5):967-977. doi:10.1111/fcp.13008
BibTeX
@article{Okcay2024,
author = {Okcay, Yagmur and Onal Sis, Cagil and Ozpolat, Muhammed Cagri and Rumanli, Zeliha and Ulusoy, Kemal Gokhan and Yildiz, Oguzhan and Vural, Ismail Mert},
title = {The relaxation effect of endocannabinoid anandamide on isolated rat bladder and vas deferens tissues and possible mechanisms},
journal = {Fundamental & Clinical Pharmacology},
year = {2024},
volume = {38},
number = {5},
pages = {967--977},
doi = {10.1111/fcp.13008}
}
EUVIMED